4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-111284
Chief Financial Officer sold 9,869 shares at $48.26 ($476,278)
- Chief Financial Officer gave 750 shares (gift)
- Chief Financial Officer acquired 16,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Prasad Raju · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-14 | Exercise or conversion : show line 1 in the form | +10,000 | 16,767 | D | ||
| 2026-03-14 | Exercise or conversion : show line 2 in the form | +6,875 | 23,642 | D | ||
| 2026-03-16 | Sale : show line 3 in the form | −5,848 | $48.26 | $282,224 | 17,794 | D |
| 2026-03-16 | Sale : show line 4 in the form | −4,021 | $48.26 | $194,053 | 13,773 | D |
| 2026-03-16 | Gift : show line 5 in the form | −750 | 13,023 | D | ||
| Open-market sales · 9,869 sh · avg $48.26 · $476,278 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-14 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −10,000 | 10,000 | D |
| 2026-03-14 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −6,875 | 20,625 | D |
Loading xslF345X05/ownership.xml…